Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||Determination of Sb(III) and total Sb in antileishmanial drugs by spectrophotometric flow-injection hydride generation|
|Author:||de Figueiredo, EC|
|Abstract:||A spectrophotometric procedure based on hydride generation and flow analysis is proposed for determination of antimony (III) [Sb(III)] and total antimony (Sb) in pharmaceutical samples. Firstly, Sb(III) reacts with hydrogen species generated in the system, forming antimony hydride. The reaction leads to a decrease in the permanganate concentration and, hence, in the intensity of the color of this specie, which is spectrophotometrically measured at 528 nm. Total Sb is determined as Sb(III) after Sb(V) reduction using 0.02% (m/v) KI. Some parameters, such as the number of channels of the gas phase separator, injection volume, coil length, and KBH 4 concentration, are investigated. The system presents a frequency of ca. 100 h(-1) and precision < 3.0% expressed as relative standard deviation (RSD) of 30 measurements using a 3.0 mg L-1 Sb(III) solution]. The analytical curve ranging from 0.5 mg L-1 to 5.0 mg L-1 (r > 0.998; n=5) permits limit of detection (LOD) and limit of quantification (LOQ) of 83 and 250 mu g L-1 . For total Sb, the accuracy is checked by atomic absorption spectrometry applying the t test and the results are in accordance at the 95% confidence level. Recovery tests are used to check the accuracy for Sb(III) determination, and the recoveries are between 95% and 105%.|
|Editor:||Taylor & Francis Inc|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.